Celcuity Inc.
CELC- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001603454
No open-market purchases or sales by Celcuity Inc. insiders were filed in the last 90 days; 268 institutions reported holding it in 13F filings for Q3 2026, worth $4.60B in total; no superinvestor holds it.
Holders of 5% or more of CELC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Celcuity Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13G | 9.99%4.88M shares | 0.00 ppfrom 9.99% | Nov 14, 20247 filings | Jul 16, 2026 | SEC |
| Soleus Capital Master Fund, L.P. | 13G/A | 9.90%3.87M shares | – | May 18, 20224 filings | Feb 11, 2025 | SEC |
| Sullivan Brian F. | 13G/A | 9.10%4.01M shares | – | Feb 12, 20215 filings | Nov 13, 2025 | SEC |
| Perceptive Advisors LLC | 13G/A | 6.80%3.16M shares | +0.25 ppfrom 6.55% | Dec 26, 20236 filings | Feb 17, 2026 | SEC |
| RTW Investments, LP | 13G | 6.30%3.04M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.90%2.18M shares | New | Feb 4, 20251 filing | Feb 4, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
61 Schedule 13D and 13G filings on Celcuity Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 202610:48 AM ET | Bank of America Corp | 13G/A | 3.70%1.81M shares | −2.80 ppfrom 6.50%Below 5% | Sep 30, 2026 | SEC |
| Nov 16, 20269:05 AM ET | Avoro Capital Advisors LLCand 1 other | 13G/A | 3.07%1.50M shares | −3.65 ppfrom 6.72%Below 5% | Sep 30, 2026 | SEC |
| Aug 11, 20263:41 PM ET | Bank of America Corp | 13G | 6.50%3.17M shares | New | Jun 30, 2026 | SEC |
| Jul 16, 20265:57 PM ET | Baker Bros. Advisors LPand 3 others | 13G | 9.99%4.88M shares | 0.00 ppfrom 9.99% | Jul 14, 2026 | SEC |
| Jul 16, 20265:51 PM ET | Baker Bros. Advisors LPand 3 others | 13D/A | 9.99%4.88M shares | −10.00 ppfrom 19.99% | Jul 14, 2026 | SEC |
| May 15, 20268:12 AM ET | RTW Investments, LPand 1 other | 13G | 6.30%3.04M shares | New | Mar 31, 2026 | SEC |
| Mar 24, 20264:06 PM ET | Baker Bros. Advisors LPand 3 others | 13D/A | 19.99%9.58M shares | +1.09 ppfrom 18.90% | Mar 20, 2026 | SEC |
| Mar 9, 20267:17 PM ET | Growth Equity Opportunities 18 VGE, LLCand 11 others | 13D/A | 4.90%2.29M shares | −1.40 ppfrom 6.30%Below 5% | Mar 5, 2026 | SEC |
| Feb 17, 20264:00 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 6.80%3.16M shares | +0.25 ppfrom 6.55% | Dec 31, 2025 | SEC |
| Feb 17, 20269:02 AM ET | Avoro Capital Advisors LLCand 1 other | 13G | 6.72%3.11M shares | New | Dec 31, 2025 | SEC |
| Feb 12, 20265:00 PM ET | Soleus Private Equity Fund II, L.P.and 8 others | 13G/A | 3.90%1.81M shares | –Below 5% | Dec 31, 2025 | SEC |
| Jan 16, 20265:30 PM ET | Growth Equity Opportunities 18 VGE, LLCand 11 others | 13D/A | 6.30%2.91M shares | −1.80 ppfrom 8.10% | Jan 14, 2026 | SEC |
| Nov 14, 20254:06 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 1.60%658.4K shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 13, 20255:33 PM ET | Sullivan Brian F. | 13G/A | 9.10%4.01M shares | – | Sep 30, 2025 | SEC |
| Nov 13, 20255:30 PM ET | Laing Lance G. | 13G/A | 3.60%1.57M shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 18, 20256:02 PM ET | Growth Equity Opportunities 18 VGE, LLCand 13 others | 13D/A | 8.10%3.54M shares | – | Aug 14, 2025 | SEC |
| Aug 4, 20255:46 PM ET | Perceptive Advisors LLCand 2 others | 13G | 6.55%2.67M shares | +2.24 ppfrom 4.31% | Jul 30, 2025 | SEC |
| Aug 4, 20255:44 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 4.31%1.63M shares | −2.09 ppfrom 6.40%Below 5% | Jun 30, 2025 | SEC |
| Aug 1, 20255:41 PM ET | Baker Bros. Advisors LPand 3 others | 13D | 18.90%7.75M shares | +7.60 ppfrom 11.30% | Aug 1, 2025 | SEC |
| Apr 7, 20257:04 PM ET | Baker Bros. Advisors LPand 3 others | 13G/A | 11.30%4.26M shares | +4.10 ppfrom 7.20% | Mar 31, 2025 | SEC |
| Feb 14, 20255:14 PM ET | Commodore Capital LPand 1 other | 13G/A | 2.90%1.10M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20254:15 PM ET | Baker Bros. Advisors LPand 3 others | 13G/A | 7.20%2.68M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:15 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 6.40%2.36M shares | – | Dec 31, 2024 | SEC |
| Feb 11, 20254:00 PM ET | Soleus Capital Master Fund, L.P.and 8 others | 13G/A | 9.90%3.87M shares | – | Dec 31, 2024 | SEC |
| Feb 4, 20253:45 PM ET | BlackRock, Inc. | 13G | 5.90%2.18M shares | New | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Commodore Capital LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Soleus Private Equity Fund II, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Baker Bros. Advisors LP | 13GOld format | – | New | – | SEC |
| Oct 7, 2024 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Jun 10, 2024 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Commodore Capital LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Soleus Capital Master Fund, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2024 | Laing Lance G. | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2024 | Sullivan Brian F. | 13G/AOld format | – | – | – | SEC |
| Dec 26, 2023 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Commodore Capital LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Soleus Capital Master Fund, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Venrock Healthcare Capital Partners II, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 2, 2023 | Sullivan Brian F. | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2023 | Laing Lance G. | 13G/AOld format | – | – | – | SEC |
| Sep 12, 2022 | Growth Equity Opportunities 18 VGE, LLC | 13D/AOld format | – | – | – | SEC |
| May 25, 2022 | Venrock Healthcare Capital Partners II, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
18 notices from officers, directors and other affiliates planning to sell Celcuity Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jul 14, 20269:45 PM ET | 667, L.P.Former affiliate | 261.4K | $26.8M | Jul 14, 2026 | Goldman Sachs & Co. LLC | SEC |
| Jul 14, 20269:43 PM ET | Baker Brothers Life Sciences, L.P.Former affiliate | 2.84M | $291.0M | Jul 14, 2026 | Goldman Sachs & Co. LLC | SEC |
| May 4, 20265:39 PM ET | Buller Richard EDirector | 6.00K | $842.8K | May 4, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| May 4, 20262:18 PM ET | Dalvey DavidDirector | 25.0K | $3.52M | May 4, 202610b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Mar 31, 20264:38 PM ET | Buller Richard EDirector | 6.00K | $661.6K | Mar 31, 202610b5-1 | Stifel Nicolaus & Company Inc | SEC |
| Jan 27, 202612:21 PM ET | Dalvey DavidDirector | 20.0K | $2.40M | Jan 27, 202610b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Dec 5, 20255:31 PM ET | Buller Richard EDirector | 3.00K | $317.0K | Dec 5, 2025 | Stifel Nicolaus & Company Inc | SEC |
| Dec 1, 20255:46 PM ET | Buller Richard EDirector | 1.10K | $107.9K | Dec 1, 2025 | Stifel Nicolaus & Company Inc | SEC |
| Nov 21, 20251:41 PM ET | Dalvey DavidDirector | 15.0K | $1.50M | Nov 21, 202510b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Nov 20, 20254:33 PM ET | Buller Richard EDirector | 3.90K | $377.3K | Nov 20, 2025 | Stifel Nicolaus & Company Inc | SEC |
| Jul 28, 20252:52 PM ET | Brightstone Venture Capital Fund LPDirector | 100.0K | $4.40M | Jul 28, 202510b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Jul 28, 20252:00 PM ET | Dalvey DavidDirector | 9.32K | $420.8K | Jul 28, 202510b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Aug 23, 202410:27 AM ET | Buller Richard EDirector | 700 | $11.9K | Aug 23, 202410b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| Apr 24, 202410:35 AM ET | Buller Richard EDirector | 700 | $11.9K | Apr 24, 202410b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| Dec 20, 202310:34 AM ET | Buller Richard EDirector | 700 | $10.1K | Dec 20, 202310b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| Dec 7, 20233:41 PM ET | Dalvey DavidDirector | 25.0K | $372.8K | Dec 7, 2023 | Craig Hallum Capital Group LLC | SEC |
| Aug 30, 202310:58 AM ET | Buller Richard EDirector | 700 | $6.50K | Aug 30, 202310b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| Jun 23, 20231:07 PM ET | Buller Richard EDirector | 600 | $7.07K | Jun 23, 202310b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |